Use the Search Fields to Find Information
Page 62 of 373
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
Please use this link to access this publication. Abstract Introduction and Aims Recent years have witnessed increased attention to how cannabis use impacts the use
October 3, 2024
Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey
Abstract People report substituting cannabis for pain medications, but whether cannabidiol (CBD) is used similarly remains unknown. CBD products can be CBD alone (isolate), hemp
April 16, 2024
Subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety
Please use this link to access this publication: https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0078/html Abstract Social anxiety disorder (SAD) is a debilitating disorder, characterized by fear and anxiety in social situations.
November 30, 2023
Subjective and physiological effects after controlled Sativex and oral THC administration
Abstract Sativex is a cannabis-plant extract delivering nearly 1:1 Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) by oromucosal spray. It has been suggested that CBD attenuates THC-induced
November 16, 2023
Subanalyses concerning “Differential impact of Cannabis abuse on neurological disorders
Please use this link to access this publication.
February 7, 2026
Subacute cannabidiol alters genome-wide DNA methylation in adult mouse hippocampus
Please use this link to access this publication. Abstract Use of cannabidiol (CBD), the most abundant non-psychoactive compound found in cannabis (Cannabis sativa), has recently
July 2, 2024
Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer’s dementia (THC-AD)
Please use this link to access this publication. Abstract Agitation is a common complication of Alzheimer’s dementia (Agit-AD) associated with substantial morbidity, high healthcare service
May 20, 2024
Study protocol of a pilot randomized controlled trial of transcranial direct current stimulation paired with reappraisal training for treatment of cannabis use disorder
Abstract Introduction As legalization of cannabis products continues, cannabis use becomes more prevalent, and concerns regarding cannabis use disorder (CUD) rise, improving CUD treatment has
March 1, 2026
Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia
Abstract Cannabidiol (CBD) exhibits anti-inflammatory and neuroprotective properties and is suggested to be effective in the pre-clinical and clinical treatment of illnesses of the central
April 16, 2024
Studies Investigating the Mechanisms of the Cardioprotective Effects of Cannabidiol
The phytocannabinoid cannabidiol (CBD) has a complex pharmacology which is thought to include, but is not limited to, an ability to act as an inverse
September 19, 2019
Page 62 of 373